Iva Selke Krulichová

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 4

Top Topics

Clinical Evaluation

Top Venues

European journal of clinical pharmacology

Expert review of pharmacoeconomics & outcomes research

Current medical research and opinion

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Iva Selke Krulichová, Gisbert W Selke, Marion Bennie, Mohammadhossein Hajiebrahimi, Fredrik Nyberg, Jurij Fürst, Kristina Garuolienė, Elisabetta Poluzzi, Juraj Slabý, Corinne Zara Yahni, Mattia Altini, Maria Pia Fantini, Václav Kočí, Stuart McTaggart, Caridad Pontes, Chiara Reno, Simona Rosa, Marta Turu Pedrola, Mitja Udovič, Björn Wettermark
Comparison of drug prescribing before and during the COVID-19 pandemic: A cross-national European study. Pharmacoepidemiology and drug safety 31 (10) (2022)
Iva Selke Krulichová, Gisbert W Selke, Petra A Thürmann
Trends and patterns in EU(7)-PIM prescribing to elderly patients in Germany. European journal of clinical pharmacology 77 (10) (2021)
Brian B Godman, Andrew Hill, Steven R A Simoens, Gisbert W Selke, Iva Selke Krulichová, Carolina Zampirolli Dias, Antony Paul Martin, Wija Oortwijn, Angela Timoney, Lars L Gustafsson, Luka Voncina, Hye-Young Kwon, Jolanta Gulbinovic, Dzintars Gotham, Janet Wale, Wânia Cristina da Silva, Tomasz Bochenek, Eleonora Allocati, Amanj Baker Kurdi, Olanyika O Ogunleye, Johanna Catharina Meyer, Iris Hoxha, Admir Malaj, Christian Hierländer, Robert Sauermann, Wouter Hamelinck, Guenka Petrova, Ott Laius, Irene Langner, John N Yfantopoulos, Roberta Joppi, Arianit Jakupi, Ieva Greiciute-Kuprijanov, Patricia Vella Bonanno, Jf Hans Piepenbrink, Vincent de Valk, Magdalene Wladysiuk, Vanda Marković-Peković, Ileana Mardare, Jurij Fürst, Dominik Tomek, Mercè Obach, Corinne Zara Yahni, Caridad Pontes, Stuart McTaggart, Tracey-Lea Laba, Øyvind Melien, Durhane Wong-Rieger, Seung Jin Bae, Ruaraidh A Hill
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications. Expert review of pharmacoeconomics & outcomes research 21 (4) (2021)
Iva Selke Krulichová, Gisbert W Selke, Uwe Eichler, Veronika Lappe, Brian B Godman, Ingrid Schubert
Impact of EU risk assessment process and administrative regulations for manufacturers of combined hormonal contraceptive prescribing. An analysis of developments in Germany and the implications. Current medical research and opinion 35 (4) (2018)